Non-steroidal anti-inflammatory drugs inhibit cyclo-oxygenase. Loss of COX-1-derived prostaglandins removes the mucus and bicarbonate protection of the gastric and duodenal lining and impairs platelet function, so they can reopen a recently bleeding ulcer; and in patients with aspirin-exacerbated respiratory disease the blocked cyclo-oxygenase pathway diverts arachidonic acid towards leukotrienes, precipitating bronchospasm, a reaction that cross-reacts with essentially all non-selective NSAIDs. Paracetamol acts mainly centrally, has negligible effects on gastric mucosa and platelets and does not provoke bronchospasm at therapeutic doses, so it is the first-line analgesic for this patient, 1 g every four to six hours to a maximum of 4 g a day in a healthy adult, with a weak opioid added if pain is not controlled; the main hazard is hepatotoxicity in overdose. Options B and C are non-selective NSAIDs and would threaten both the stomach and the airway. Option D is the drug that caused the asthma and also inhibits platelets irreversibly. The same logic makes paracetamol the analgesic of choice for patients on anticoagulants and those with renal impairment. Exam tip: asthma, ulcer, anticoagulant or kidney disease all point to paracetamol first and NSAIDs last.